Eliem Therapeutics Inc. (ELYM) NASDAQ
$2.74 (0.02) (-0.73%)
Market Cap: $76.10M
As of 03/28/24 04:00 PM EDT. Market closed.
Eliem Therapeutics Inc. (ELYM)
NASDAQ
$2.74
(0.02) (-0.73%)
Market Cap: $76.10M
As of 03/28/24 04:00 PM EDT. Market closed.
eliem therapeutics is a biotechnology company delivering therapies that empower patients to live on their own terms. headquartered in seattle with r&d primarily in cambridge, uk, eliem channels its experience, energy, and passion for improving patients’ quality of life by developing and commercializing potentially “best-in-class” drug candidates to treat neuronal excitability disorders. ... read more
eliem therapeutics is a biotechnology company delivering therapies that empower patients to live on their own terms. headquartered in seattle with r&d primarily in cambridge, uk, eliem channels its experience, energy, and passion for improving patients’ quality of life by developing and commercializing potentially “best-in-class” drug candidates to treat neuronal excitability disorders. these conditions—such as chronic pain, depression, epilepsy, and anxiety—cause deep suffering for tens of millions of people each day. at its core, the eliem team is motivated by the promise of helping patients live happier, more fulfilling lives. eliem is a publicly traded company (nasdaq: elym) read our community guidelines here: https://eliemtx.com/community-engagement-guidelines/ read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Morisset Valerie | EVP, R&D AND CSO | Sep 20, 2023 | Option Exercise | $0.00 | 20,728 | 14 | 487,460 | Mar 04, 2024, 11:07 AM |
Morisset Valerie | EVP, R&D and CSO | Mar 10, 2023 | Option Exercise | $0.00 | 316,410 | 523 | 466,732 | Mar 14, 2023, 05:04 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Aug 12, 2021 | Buy | $12.50 | 3,200,000 | 40,000,000 | 10,599,586 | Aug 16, 2021, 04:47 PM |
AI ETI LLC | 10% Owner | Aug 12, 2021 | Buy | $12.50 | 800,000 | 10,000,000 | 5,009,400 | Aug 16, 2021, 04:21 PM |
Owner | Relationship | Date | Value($) |
Morisset Valerie | EVP, R&D AND CSO | 09/20/2023 | 14 |
Morisset Valerie | EVP, R&D and CSO | 03/10/2023 | 523 |
RA CAPITAL MANAGEMENT, L.P. | Director | 08/12/2021 | 40,000,000 |
AI ETI LLC | 10% Owner | 08/12/2021 | 10,000,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 13,179,181 | 0.55% | 0.22% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 811,680 | 0.03% | No change | Growth |
GEODE CAPITAL MANAGEMENT, LLC | 66,626 | 0.00002% | No change | Other |
BLACKROCK INC. | 31,145 | 0% | -0.53% | Other |
TUDOR INVESTMENT CORP ET AL | 29,490 | 0.00064% | -0.72% | Event Driven, Other |
RENAISSANCE TECHNOLOGIES LLC | 10,603 | 0.00004% | New | Other |
Period of Report: 09/30/2023
10-K/10-Q Filings: View